National Heart, Lung, and Blood Institute (NHLBI): Multiple Myeloma trials

The registry lists 11 Multiple Myeloma studies with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor. 0 are open to participants now and 5 have results posted.

Phase 1 2Phase 2 4Phase 3 3No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Dendritic Cell/Myeloma Fusion Vaccine for Multiple Myeloma (BMT CTN 1401)CompletedNCT02728102Phase 2Results posted
• Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)CompletedNCT02440464Phase 2Results posted
• Continued, Long-Term Follow-Up and Lenalidomide Maintenance Therapy for Patients on BMT CTN 0702 Protocol (BMT CTN 07LT)CompletedNCT02322320Phase 3Results posted
• Stem Cell Transplant With Lenalidomide Maintenance in Patients With Multiple Myeloma (BMT CTN 0702)CompletedNCT01109004Phase 3Results posted
• Stem Cell Transplantation in Individuals With Multiple Myeloma (BMT CTN 0102)CompletedNCT00075829Phase 3Results posted
• A Pilot Study of the Safety and Activity of Escalating Doses of ON 01910.Na in Patients With Relapsed Mantle Cell Lymphoma, Multiple Myeloma, Chronic Lymphocytic Leukemia, and Related Lymphoid MalignanciesCompletedNCT00861510Phase 1
• Natural Killer Cells and Bortezomib to Treat CancerCompletedNCT00720785Phase 1
• Blood and Marrow Transplant Clinical Research NetworkCompletedNCT00023530Not applicable
• The Role of Cyclosporine in Blood Cell Transplants With T-Cell Add-Back for Blood CancersCompletedNCT00001873Phase 2
• Comparing Treatments for Multiple MyelomaCompletedNCT00001750Phase 2
• Bone Marrow Transplant Studies for Safe and Effective Treatment of LeukemiaCompletedNCT00001623Not applicable